Full Text View
Tabular View
No Study Results Posted
Related Studies
New Therapeutic Strategies for Patients With Ewing's Sarcoma Family of Tumors, High Risk Rhabdomyosarcoma, and Neuroblastoma
This study has been completed.
Study NCT00001335   Information provided by National Institutes of Health Clinical Center (CC)

First Received on November 3, 1999.   Last Updated on March 3, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Ewing's Sarcoma
Neuroblastoma
Rhabdomyosarcoma
Additional conditions recognized in this trial
Neuroectodermal Tumors, Primitive, Peripheral
Sarcoma
Sarcoma, Ewing's
More general conditions related to this trial
Myosarcoma
Neoplasms
Neoplasms by Histologic Type
Neoplasms, Bone Tissue
Neoplasms, Connective and Soft Tissue
Neoplasms, Connective Tissue
Neoplasms, Germ Cell and Embryonal
Neoplasms, Glandular and Epithelial
Neoplasms, Muscle Tissue
Neoplasms, Nerve Tissue
Neoplasms, Neuroepithelial
Neuroectodermal Tumors
Neuroectodermal Tumors, Primitive
Osteosarcoma
Interventions listed in this trial
ADR-529
Topotecan
G-CSF
Additional drug interventions recognized in this trial
Razoxane
More general drug interventions related to this trial
Antineoplastic Agents
Cardiovascular Agents
Chelating Agents
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Therapeutic Uses
Topoisomerase I Inhibitors
Topoisomerase Inhibitors
Sponsors listed in this trial
National Cancer Institute (NCI)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services